Therapeutic Advances in Chronic Disease : Impact Factor & More
eISSN: 2040-6231pISSN: 2040-6223
Open AccessShare this on:
Key Metrics
CiteScore 
5.4
Impact Factor
< 5
SJR
Q2Medicine (miscellaneous)
SNIP
1.43
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Therapeutic Advances in Chronic Disease
Therapeutic Advances in Chronic Disease Journal Specifications
| Overview | |
| Publisher | SAGE PUBLICATIONS LTD |
| Language | English |
| Frequency | Continuous publication |
| Article Processing Charges | USD 2300 |
| Publication Time | 12 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Frequency | Continuous publication |
| Publication Start Year | 2010 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY, CC BY-NC |
| OA statement | Visit website |
View less
Planning to publish in Therapeutic Advances in Chronic Disease ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Therapeutic Advances in Chronic Disease
Frailty and its association with mental health and quality of life in multiple sclerosis: A cross-sectional study
- 1 Jan 2026
- Therapeutic Advances in Chronic Disease
Factors associated with disease knowledge and medication adherence among rheumatoid arthritis patients attending a private rheumatology clinic: A cross-sectional study
- 1 Jan 2026
- Therapeutic Advances in Chronic Disease
Treatment of vitiligo with ruxolitinib cream in the TRuE-V1 and TRuE-V2 studies: a plain language summary of publication
- 1 Nov 2025
- Therapeutic Advances in Chronic Disease
The evolving roles of fetuin-A in type 2 diabetes mellitus and its potential clinical implications: a review
- 1 Nov 2025
- Therapeutic Advances in Chronic Disease
Short- and long-term complications of insulin pump therapy in children and adolescents with type 1 diabetes: a multicenter cross-sectional study from Saudi Arabia
- 1 Oct 2025
- Therapeutic Advances in Chronic Disease
Patterns of use and dose optimization of renin-angiotensin system modulators among chronic heart failure patients with reduced ejection fraction in resource-limited settings: a multicenter cohort study
- 1 Oct 2025
- Therapeutic Advances in Chronic Disease
Frailty and its association with mental health and quality of life in multiple sclerosis: A cross-sectional study
- 1 Jan 2026
- Therapeutic Advances in Chronic Disease
Factors associated with disease knowledge and medication adherence among rheumatoid arthritis patients attending a private rheumatology clinic: A cross-sectional study
- 1 Jan 2026
- Therapeutic Advances in Chronic Disease
Treatment of vitiligo with ruxolitinib cream in the TRuE-V1 and TRuE-V2 studies: a plain language summary of publication
- 1 Nov 2025
- Therapeutic Advances in Chronic Disease
The evolving roles of fetuin-A in type 2 diabetes mellitus and its potential clinical implications: a review
- 1 Nov 2025
- Therapeutic Advances in Chronic Disease
Short- and long-term complications of insulin pump therapy in children and adolescents with type 1 diabetes: a multicenter cross-sectional study from Saudi Arabia
- 1 Oct 2025
- Therapeutic Advances in Chronic Disease
Patterns of use and dose optimization of renin-angiotensin system modulators among chronic heart failure patients with reduced ejection fraction in resource-limited settings: a multicenter cohort study
- 1 Oct 2025
- Therapeutic Advances in Chronic Disease
FAQs on Therapeutic Advances in Chronic Disease
How long has Therapeutic Advances in Chronic Disease been actively publishing? 
What is the publishing frequency of Therapeutic Advances in Chronic Disease?
How many articles did Therapeutic Advances in Chronic Disease publish last year?
What is the eISSN & pISSN for Therapeutic Advances in Chronic Disease?
What is Citescore for Therapeutic Advances in Chronic Disease?
What is SNIP score for Therapeutic Advances in Chronic Disease?
What is the SJR for Therapeutic Advances in Chronic Disease?
Who is the publisher of Therapeutic Advances in Chronic Disease?
